Whole-genome screening in ankylosing spondylitis: evidence of non-MHC genetic-susceptibility loci.

Ankylosing spondylitis (AS) is a common inflammatory arthritis predominantly affecting the axial skeleton. Susceptibility to the disease is thought to be oligogenic. To identify the genes involved, we have performed a genomewide scan in 185 families containing 255 affected sibling pairs. Two-point and multipoint nonparametric linkage analysis was performed. Regions were identified showing "suggestive" or stronger linkage with the disease on chromosomes 1p, 2q, 6p, 9q, 10q, 16q, and 19q. The MHC locus was identified as encoding the greatest component of susceptibility, with an overall LOD score of 15.6. The strongest non-MHC linkage lies on chromosome 16q (overall LOD score 4.7). These results strongly support the presence of non-MHC genetic-susceptibility factors in AS and point to their likely locations.

[1]  D. Weeks,et al.  A genome-wide screen for susceptibility loci in ankylosing spondylitis. , 2004, Arthritis and rheumatism.

[2]  B. Dijkmans,et al.  Interleukin-1beta and interleukin-1 receptor antagonist gene polymorphisms in ankylosing spondylitis. , 2002, Rheumatology.

[3]  M. Field,et al.  A polymorphism within the interleukin 1 receptor antagonist (IL-1Ra) gene is associated with ankylosing spondylitis. , 2001, Rheumatology.

[4]  A Calin,et al.  Recurrence risk modelling of the genetic susceptibility to ankylosing spondylitis , 2000, Annals of the rheumatic diseases.

[5]  T. Wienker,et al.  Genomewide scan in german families reveals evidence for a novel psoriasis-susceptibility locus on chromosome 19p13. , 2000, American journal of human genetics.

[6]  D. Weeks,et al.  Polymorphisms of the CYP2D6 gene increase susceptibility to ankylosing spondylitis. , 2000, Human molecular genetics.

[7]  A. Calin,et al.  The X-chromosome and susceptibility to ankylosing spondylitis. , 2000, Arthritis and rheumatism.

[8]  M. Dougados,et al.  The familial form of spondylarthropathy: a clinical study of 115 multiplex families. Groupe Français d'Etude Génétique des Spondylarthropathies. , 2000, Arthritis and rheumatism.

[9]  E S Lander,et al.  Genomewide search in Canadian families with inflammatory bowel disease reveals two novel susceptibility loci. , 2000, American journal of human genetics.

[10]  K Lange,et al.  A multipoint method for detecting genotyping errors and mutations in sibling-pair linkage data. , 2000, American journal of human genetics.

[11]  L Kruglyak,et al.  Exact multipoint quantitative-trait linkage analysis in pedigrees by variance components. , 2000, American journal of human genetics.

[12]  J. Riley,et al.  Psoriasis susceptibility locus in chromosome region 3q21 identified in patients from southwest Sweden , 1999, European Journal of Human Genetics.

[13]  K. Kendler,et al.  Replication of linkage studies of complex traits: an examination of variation in location estimates. , 1999, American journal of human genetics.

[14]  E. Märker-Hermann,et al.  Association of different tumor necrosis factor alpha promoter allele frequencies with ankylosing spondylitis in HLA-B27 positive individuals. , 1998, Arthritis and rheumatism.

[15]  J R O'Connell,et al.  PedCheck: a program for identification of genotype incompatibilities in linkage analysis. , 1998, American journal of human genetics.

[16]  M. Ehm,et al.  Autosomal genomic scan for loci linked to obesity and energy metabolism in Pima Indians. , 1998, American journal of human genetics.

[17]  N J Cox,et al.  Allele-sharing models: LOD scores and accurate linkage tests. , 1997, American journal of human genetics.

[18]  P Wordsworth,et al.  Susceptibility to ankylosing spondylitis in twins: the role of genes, HLA, and the environment. , 1997, Arthritis and rheumatism.

[19]  J. Terwilliger,et al.  Two stage genome–wide search in inflammatory bowel disease provides evidence for susceptibility loci on chromosomes 3, 7 and 12 , 1996, Nature Genetics.

[20]  K Lange,et al.  Descent graphs in pedigree analysis: applications to haplotyping, location scores, and marker-sharing statistics. , 1996, American journal of human genetics.

[21]  A Calin,et al.  HLA class I associations of ankylosing spondylitis in the white population in the United Kingdom. , 1996, Annals of the rheumatic diseases.

[22]  J. Idle,et al.  Relationship between genotype for the cytochrome P450 CYP2D6 and susceptibility to ankylosing spondylitis and rheumatoid arthritis. , 1996, Annals of the rheumatic diseases.

[23]  E. Lander,et al.  Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results , 1995, Nature Genetics.

[24]  Patricia Woo,et al.  Oxford textbook of rheumatology , 1995 .

[25]  K. Siminovitch,et al.  Investigating the genetic basis for ankylosing spondylitis. Linkage studies with the major histocompatibility complex region. , 1994, Arthritis and rheumatism.

[26]  S. C. Jenkins,et al.  Chromosome–specific microsatellite sets for fluorescence–based, semi–automated genome mapping , 1994, Nature Genetics.

[27]  M. De Vos,et al.  Gut inflammation in the spondyloarthropathies: clinical, radiologic, biologic and genetic features in relation to the type of histology. A prospective study. , 1991, The Journal of rheumatology.

[28]  N. Risch.  Linkage strategies for genetically complex traits. II. The power of affected relative pairs. , 1990, American journal of human genetics.

[29]  J. Woodrow.  Genetics of the spondarthropathies. , 1988, Bailliere's clinical rheumatology.

[30]  X. le Loët,et al.  [Genetic study of a family of subjects with ankylosing spondylitis]. , 1987, Revue du rhumatisme et des maladies osteo-articulaires.

[31]  D. Gladman,et al.  Discordance between HLA-B27 and ankylosing spondylitis: a family investigation. , 1986, The Journal of rheumatology.

[32]  A. Cats,et al.  Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. , 1984, Arthritis and rheumatism.

[33]  A Calin,et al.  Genetic differences between B27 positive patients with ankylosing spondylitis and B27 positive healthy controls. , 1983, Arthritis and rheumatism.

[34]  J. Vanderlinden.  HL-A 27 AND ANKYLOSING SPONDYLITIS , 1975 .

[35]  A. Cats,et al.  HL-A 27 AND ANKYLOSING SPONDYLITIS , 1975, The Lancet.

[36]  R D Sturrock,et al.  Ankylosing spondylitis and HL-A 27. , 1973, Lancet.

[37]  P I Terasaki,et al.  High association of an HL-A antigen, W27, with ankylosing spondylitis. , 1973, The New England journal of medicine.

[38]  A. Polman,et al.  Hereditary Factors in Rheumatoid Arthritis and Ankylosing Spondylitis , 1961, Annals of the rheumatic diseases.

[39]  E. L. Persons,et al.  Ankylosing Spondylitis , 1955, GP.

[40]  A. Barton,et al.  A single nucleotide polymorphism in exon 1 of cytotoxic T-lymphocyte-associated-4 (CTLA-4) is not associated with rheumatoid arthritis. , 2000, Rheumatology.

[41]  M. Wagner,et al.  A test statistic to detect errors in sib-pair relationships. , 1998, American journal of human genetics.

[42]  H. Cordell,et al.  Confidence intervals for relative risk estimates from affected‐sib‐pair data , 1997, Genetic epidemiology.

[43]  R. Campbell,et al.  Mapping of 10 novel microsatellites in the MHC class III region: application to the study of autoimmune disease. , 1997, The Journal of rheumatology.

[44]  J. Skomsvoll,et al.  HLA-B27 negative ankylosing spondylitis in a father and a son. , 1995, Scandinavian journal of rheumatology.

[45]  N Risch,et al.  Assessing the role of HLA-linked and unlinked determinants of disease. , 1987, American journal of human genetics.

[46]  A. Cats,et al.  The risk of developing ankylosing spondylitis in HLA-B27 positive individuals: a family and population study. , 1983, British journal of rheumatology.